Skip to content

Multi-disciplinary Diagnosis and Treatment Process and Evaluation System for Children With Sleep Disordered Breathing and Malocclusion

A Multicenter Study of Establishing the Multi-disciplinary Cooperative Diagnosis and Treatment Process and Evaluation System for Children With Sleep Disordered Breathing and Malocclusion

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03451318
Enrollment
400
Registered
2018-03-01
Start date
2018-03-02
Completion date
2020-05-30
Last updated
2018-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Malocclusion

Brief summary

The aim of this study is to compare the efficacy and safety of drug therapy, tonsillar adenoidectomy only, orthodontic treatment only and tonsillar adenoidectomy plus orthodontic treatment in children with obstructive sleep apnea hypopnea syndrome (OSAHS) and malocclusion. In this study, we hope to improve children's OSAH in function, three-dimensional shape and subjective and objective symptoms of sleep breathing through tonsillar adenoidectomy plus orthodontic treatment.

Interventions

DRUGMometasone Furoate Nasal Spray

Mometasone Furoate Nasal Spray NASONEX

PROCEDUREtonsillar adenoidectomy

tonsillar adenoidectomy

PROCEDUREMaxillary expander plus Twin-Block

Twin-block appliance combined with maxillary expander

Sponsors

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
CollaboratorOTHER
Shanghai Children's Hospital
CollaboratorOTHER
Shanghai Stomotological Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed as mild to moderate OSAHS 2. Tonsil and/or adenoid hypertrophy 3. Narrow dental arch and / or mandibular retrusion (ANB value≥ 4.5) 4. The guardian / child can understand the study and sign the informed consent

Exclusion criteria

1. Patients with nasal obstruction disease 2. The pathological obesity 3. Patients with systemic disease 4. Patient with central sleep apnea/hypopnea syndrome

Design outcomes

Primary

MeasureTime frameDescription
Obstructive Apnea Index(OAI)/ Apnea Hypopnea Index (AHI) in PolySomnoGraphy (PSG)change from baseline at 7 months,1 year & 2 years post-treatmentOAI/AHI (which are in negative correlation with oxygen saturation) decrease after treatment

Secondary

MeasureTime frameDescription
Low arterial Oxygen Saturation (LSaO2) in PSGchange from baseline at 7 months,1 year & 2 years post-treatmentLSaO2 increase after treatment
Airway volume change as shown on Cone Beam Computer Tomography (CBCT)change from baseline at 7 months post-treatmentAirway volume increase after treatment
ANB, Frankfort plane- Mandibular plane Angle (FMA) measurement using X-ray cephalometrics.change from baseline at 7 months,1 year & 2 years post-treatmentANB & FMA (face development indicators) become normal after treatment
Assessment of subjective efficacy by using a questionnaire on children's sleep symptomschange from baseline at 7 months,1 year & 2 years post-treatmentSleep quality improve after treatment.

Countries

China

Contacts

Primary ContactYuanyuan Li, Doctor
liyuanyuan831@sina.com86-18817367760
Backup ContactHuanbqing Shan
362911628@qq.com86-13564158276

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026